Dr Reddy’s Revises Wockhardt Terms In Light Of COVID-19 Slump
Deal Restructured After Wockhardt Unit’s Sales Fall In March And April
Dr Reddy’s has completed its deal for Wockhardt’s branded generics business. However, the two companies have renegotiated the financial terms of the deal following the impact of the COVID-19 pandemic on Wockhardt’s business.
